ANDA 63333, held by Pfizer. Cefoperazone Sodium.
As of Nov 16, 2026, ANDA 63333 (Cefobid), held by Pfizer, was first approved by FDA on Mar 31, 1995, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1995 | Original application | Approved | None posted |
| CefobidEQ 1GM BASE/VIAL · injectable;injection | Cefoperazone Sodium | Discontinued |
| CefobidEQ 2GM BASE/VIAL · injectable;injection | Cefoperazone Sodium | Discontinued |
| Dec 29, 1995 | Supplement 1Manufacturing | Approved | None posted |
| Mar 31, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters